Analysts review Cytokinetics Inc’s rating

Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $9.55 million. Then, HENDERSON […]

CYTK Shares Experience Decline in Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cytokinetics Inc shares valued at $2,202,606 were sold by Malik Fady Ibraham on Mar 05 ’24. At $67.56 per share, Malik Fady Ibraham sold 32,604 shares. The insider’s holdings dropped to 138,973 shares worth […]

Recent Insider Activity Could Benefit Cytokinetics Inc (CYTK)

Cytokinetics Inc’s filing revealed that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $8.86 million. Then, HENDERSON JOHN […]

CYTK short interest jump by 6.54%, reflecting negative sentiment

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cytokinetics Inc shares valued at $2,202,606 were sold by Malik Fady Ibraham on Mar 05 ’24. At $67.56 per share, Malik Fady Ibraham sold 32,604 shares. The insider’s holdings dropped to 138,973 shares worth […]

Cytokinetics Inc’s latest rating changes from various analysts

CHWY Stock

In a filing, Cytokinetics Inc revealed its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $2.2 million on Mar 05 ’24. In the deal valued at $67.56 per share,32,604 shares were sold. As a result of this transaction, Malik Fady Ibraham now holds 138,973 shares worth roughly $8.95 million. Then, HENDERSON […]

Examining the Potential Price Growth of Cytokinetics Inc (CYTK)

Cytokinetics Inc’s filing revealed that its Director HENDERSON JOHN T unloaded Company’s shares for reported $0.38 million on Feb 14. In the deal valued at $76.48 per share,5,000 shares were sold. As a result of this transaction, HENDERSON JOHN T now holds 42,632 shares worth roughly $2.89 million. Then, Blum Robert I sold 12,500 shares, […]

Director HENDERSON JOHN T sold 5,000 shares of Cytokinetics Inc [CYTK]

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cytokinetics Inc shares valued at $382,400 were sold by HENDERSON JOHN T on Feb 14. At $76.48 per share, HENDERSON JOHN T sold 5,000 shares. The insider’s holdings dropped to 42,632 […]

Understanding the Risks of Investing in Cytokinetics Inc (CYTK)

Cytokinetics Inc’s recent filing unveils that its Director HENDERSON JOHN T unloaded Company’s shares for reported $0.38 million on Feb 14. In the deal valued at $76.48 per share,5,000 shares were sold. As a result of this transaction, HENDERSON JOHN T now holds 42,632 shares worth roughly $3.37 million. Then, Blum Robert I sold 12,500 […]

Positive sentiment towards CYTK reflected in decline in short interest

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cytokinetics Inc shares valued at $382,400 were sold by HENDERSON JOHN T on Feb 14. At $76.48 per share, HENDERSON JOHN T sold 5,000 shares. The insider’s holdings dropped to 42,632 […]